European Shorting
To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ECYT | Endocyte, Inc. | HANHAM ANN | Director | 2013-05-15 | Sell | 40,200 | $14.69 | 590.5 | -2.11 | 0.00 | 0.00 | 512.969 |  Link |
| ECYT | Endocyte, Inc. | Leamon Christopher P | Vice President of Research | 2013-05-14 | Sell | 5,000 | $14.7 | 73.5 | -2.18 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ellis P Ron | President and CEO (Click for the stocks that their CEOs have bought) | 2012-12-31 | Sell | 6,000 | $8.75 | 52.5 | 64.34 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ellis P Ron | President and CEO | 2013-03-27 | Sell | 1,500 | $12 | 18 | 19.83 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ritter Allen R | VP of Manufacturing/CMC | 2013-03-25 | Sell | 1,000 | $11 | 11 | 30.73 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Lovejoy Chandra D | VP of Regulatory Affairs | 2013-02-25 | Sell | 2,102 | $9.7 | 20.4 | 48.25 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ritter Allen R | VP of Manufacturing/CMC | 2013-02-19 | Sell | 1,000 | $10.02 | 10 | 43.51 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ritter Allen R | VP of Manufacturing/CMC | 2013-01-31 | Sell | 1,000 | $10 | 10 | 43.8 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Lovejoy Chandra D | VP of Regulatory Affairs | 2013-01-25 | Sell | 2,209 | $9.56 | 21.1 | 50.42 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ellis P Ron | President and CEO | 2012-12-31 | Sell | 6,000 | $8.75 | 52.5 | 64.34 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Lovejoy Chandra D | VP of Regulatory Affairs | 2012-12-26 | Sell | 2,209 | $9.05 | 20 | 58.9 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ritter Allen R | VP of Manufacturing/CMC | 2012-12-18 | Sell | 2,000 | $9.65 | 19.3 | 49.02 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | SANDERLING VENTURES MANAGEMENT | 10% Owner | 2011-12-21 | Buy | 3,178 | $3.18 | 10.1 | 352.2 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Lovejoy Chandra D | VP of Regulatory Affairs | 2012-11-26 | Sell | 2,209 | $8.72 | 19.3 | 64.91 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ritter Allen R | VP of Manufacturing/CMC | 2012-11-26 | Sell | 2,000 | $9 | 18 | 59.78 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Ritter Allen R | VP of Manufacturing/CMC | 2012-11-01 | Sell | 5,000 | $9.4 | 47 | 52.98 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Lovejoy Chandra D | VP of Regulatory Affairs | 2012-10-25 | Sell | 2,209 | $9.71 | 21.4 | 48.09 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Low Philip S | Chief Science Officer | 2012-09-28 | Sell | 34,000 | $9.99 | 339.7 | 43.94 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Lovejoy Chandra D | VP of Regulatory Affairs | 2012-09-25 | Sell | 2,209 | $10.28 | 22.7 | 39.88 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Leamon Christopher P | Vice President of Research | 2012-08-16 | Sell | 10,000 | $9.65 | 96.5 | 49.02 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | HANHAM ANN | Director | 2012-06-06 | Sell | 325,100 | $6.6 | 2145.7 | 117.88 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | HANHAM ANN | Director | 2012-05-16 | Sell | 27,900 | $6.65 | 185.5 | 116.24 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | HANHAM ANN | Director | 2012-05-16 | Sell | 27,900 | $6.65 | 185.5 | 116.24 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | HANHAM ANN | Director | 2012-05-15 | Sell | 147,000 | $6.87 | 1009.9 | 109.32 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Sanderling Venture Partners V, | 10% Owner | 2011-12-21 | Buy | 395,600 | $3.18 | 1258 | 352.2 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | SANDERLING VENTURES MANAGEMENT | 10% Owner | 2011-12-21 | Buy | 44,400 | $3.18 | 141.2 | 352.2 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Sanderling Venture Partners V, | 10% Owner | 2011-12-21 | Buy | 435,600 | $3.18 | 1385.2 | 352.2 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | SANDERLING VENTURES MANAGEMENT | 10% Owner | 2011-12-21 | Buy | 4,400 | $3.18 | 14 | 352.2 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | Leamon Christopher P | Vice President of Research | 2011-12-21 | Buy | 5,000 | $3.14 | 15.7 | 357.96 | 0.00 | 0.00 | 512.969 | Link |
| ECYT | Endocyte, Inc. | MIDDLETON FRED A | Director | 2011-12-19 | Buy | 24,084 | $3.13 | 75.4 | 359.42 | 0.00 | 0.00 | 512.969 | Link |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Jim Simons | 2013-03-31 | 97,100 | 0% | -48.2% | |
 Most recent portfolio changes are included for Premium Members only!
| |||||
Feedback
My Portfolios
Browse Gurus
Insider Trade Rss Update
Bookmark
This page has been successfully added into your 
RSS
Add Notes, Comments or Ask Questions
Comments